Neogen® to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Neogen Corporation announced its participation in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on January 11, 2023. Neogen's President and CEO, John Adent, will present at 8:15 a.m. Pacific Time. Interested parties can access the presentation materials and webcast through the Neogen Investor Relations website.

Neogen specializes in food and animal safety solutions, offering diagnostic test kits and genomic products.

News Market Reaction – NEOG

+4.48%

+4.48% Session move

In the trading session that priced this news, NEOG gained 4.48%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LANSING, Mich., Dec. 29, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 41^st Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 11, 2023.

John Adent, Neogen's President and Chief Executive Officer, will present at 8:15 a.m. Pacific Time.

To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.

About Neogen

Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." The company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.

CONTACT:

Bill Waelke, Investor Relations 517.372.9200, BWaelke@Neogen.com

View original content:https://www.prnewswire.com/news-releases/neogen-to-participate-in-the-41st-annual-jp-morgan-healthcare-conference-301710994.html

SOURCE Neogen Corporation

FAQ

What is Neogen's participation in the J.P. Morgan Healthcare Conference 2023?

Neogen will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023.

When will Neogen present at the J.P. Morgan Healthcare Conference?

Neogen's presentation is scheduled for 8:15 a.m. Pacific Time on January 11, 2023.

How can I access Neogen's conference presentation materials?

You can access Neogen's presentation materials via their Investor Relations website.

Who is presenting for Neogen at the J.P. Morgan Conference?

John Adent, Neogen's President and CEO, will present at the conference.

Where is the 41st Annual J.P. Morgan Healthcare Conference being held?

The conference is being held in San Francisco, California.